The GLP-1 paradox: Weight loss drugs may lead to stigma

Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday conversations, GLP-1 drugs like Ozempic and Wegovy are often framed as breakthroughs and seen as powerful new tools that can help people lose significant weight. But new research from Rice University suggests the social reality may be more complicated. In some cases, using these medications may come with more judgment than not losing weight at all.